(Q45089455)

English

Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) study

scientific article published in October 2004

Statements

Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) study (English)
Maureen C Abbott
Oral Rapamune to Inhibit Restenosis study

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit